Table 1 (abstract P304). See text for description
From: Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)
Variables | Total n= 131 | Hematological manifestations n= 55 | Absence of hematological manifestations n= 76 | P-value |
|---|---|---|---|---|
Neurological, n (%) | 26 (20) | 10 (18.2) | 16 (21.3) | 0.657 |
 Chorea | 8 (6.1) |  |  |  |
 Epilepsy | 5 (3.8) | |||
 Migraine | 4 (3) | |||
Cutaneous, n (%) | 23 (17.6) | 6 (10.9) | 17 (22.4) | 0.089 |
 Raynaud | 17 (13) |  |  |  |
 Livedo | 5 (3.1) | |||
Cardiac, n (%) | 22 (16.8) | 12 (21.8) | 10 (13.2) | 0.191 |
Renal, n (%) | 2 (1.5) | 0 (0) | 2 (2.6) | 0.225 |
aCL, n (%) | ||||
 IgG | 54 (41.2) | 24 (43.6) | 30 (39.5) | 0.633 |
 IgM | 31 (23.7) | 20 (36.4) | 11 (14.5) | 0.004* |
aB2GP, n (%) | ||||
 IgG | 59 (45) | 29 (52.7) | 30 (39.5) | 0.132 |
 IgM | 24 (18.3) | 16 (29.1) | 8 (10.5) | 0.007* |
LA, n (%) | 76 (58.5) | 37 (67.3) | 39 (52) | 0.081 |
aPL profile, n (%) | ||||
 Simple | 76 (58) | 25 (45.5) | 51 (67.1) |  |
 Double | 30 (22.9) | 13 (23.6) | 17 (22.4) | 0.008* |
 Triple | 25 (19.1) | 17 (30.9) | 8 (10.5) |  |
ANA +, n (%) | 72 (59.5) | 33 (66) | 39 (54.9) | 0.222 |